| 1 |
Hunsawong T, Buddhari D, Rungrojcharoenkit K, Suthangkornkul R, Mongkolsirichaikul D, Lohachanakul J, Tayong K, Sirikajornpan K, Rodpradit P, Poolpanichupatam Y, Klungthong C, Utennam D, Kaewhiran S, Cotrone TS, Fernandez S, Jones AR. Anti-Arbovirus Antibodies Cross-React With Severe Acute Respiratory Syndrome Coronavirus 2. Microbiol Spectr 2022;10:e0263922. [PMID: 36445096 DOI: 10.1128/spectrum.02639-22] [Reference Citation Analysis]
|
| 2 |
Ni K, Che B, Yang C, Qin Y, Gu R, Wang C, Luo M, Deng L. Emerging toolset of three-dimensional pulmonary cell culture models for simulating lung pathophysiology towards mechanistic elucidation and therapeutic treatment of SARS-COV-2 infection. Front Pharmacol 2022;13:1033043. [PMID: 36578545 DOI: 10.3389/fphar.2022.1033043] [Reference Citation Analysis]
|
| 3 |
Inoue S, Mizoguchi I, Sonoda J, Sakamoto E, Katahira Y, Hasegawa H, Watanabe A, Furusaka Y, Xu M, Yoneto T, Sakaguchi N, Terai K, Yamashita K, Yoshimoto T. Induction of potent antitumor immunity by intradermal DNA injection using a novel needle-free pyro-drive jet injector. Cancer Sci 2023;114:34-47. [PMID: 36000926 DOI: 10.1111/cas.15542] [Reference Citation Analysis]
|
| 4 |
Błaszczuk A, Michalski A, Sikora D, Malm M, Drop B, Polz-Dacewicz M. Antibody Response after SARS-CoV-2 Infection with the Delta and Omicron Variant. Vaccines (Basel) 2022;10:1728. [PMID: 36298593 DOI: 10.3390/vaccines10101728] [Reference Citation Analysis]
|
| 5 |
Rivolta F, Camilla C, Sangalli A, Chiei Gallo A, Pravettoni V. Successful fractionated undiluted doses of COVID-19 vaccine in five cases of suspected allergic reactions to the first dose. Clin Case Rep 2022;10:e6348. [PMID: 36245445 DOI: 10.1002/ccr3.6348] [Reference Citation Analysis]
|
| 6 |
Liang HY, Wu Y, Yau V, Yin HX, Lowe S, Bentley R, Ahmed MA, Zhao W, Sun C. SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19. Vaccines (Basel) 2022;10:1538. [PMID: 36146616 DOI: 10.3390/vaccines10091538] [Reference Citation Analysis]
|
| 7 |
Xu A, Hong B, Lou F, Wang S, Li W, Shafqat A, An X, Zhao Y, Song L, Tong Y, Fan H. Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention. MedComm 2022;3. [DOI: 10.1002/mco2.172] [Reference Citation Analysis]
|
| 8 |
Brynjolfsson SF, Sigurgrimsdottir H, Gudlaugsson O, Kristjansson M, Kristinsson KG, Ludviksson BR. Determining SARS-CoV-2 non-infectivity state-A brief overview. Front Public Health 2022;10:934242. [PMID: 36033758 DOI: 10.3389/fpubh.2022.934242] [Reference Citation Analysis]
|
| 9 |
Takheaw N, Liwsrisakun C, Chaiwong W, Laopajon W, Pata S, Inchai J, Duangjit P, Pothirat C, Bumroongkit C, Deesomchok A, Theerakittikul T, Limsukon A, Tajarernmuang P, Niyatiwatchanchai N, Trongtrakul K, Kasinrerk W. Correlation Analysis of Anti-SARS-CoV-2 RBD IgG and Neutralizing Antibody against SARS-CoV-2 Omicron Variants after Vaccination. Diagnostics 2022;12:1315. [DOI: 10.3390/diagnostics12061315] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 10 |
Mirzakhani M, Tahmasebi S, Dashti M, Mohammadi MR, Faghih M, Mohammadnia-afrouzi M, Gouvarchin Ghaleh HE, Amani J. Evaluation of anti-spike glycoprotein antibody and neutralizing antibody response of different vaccine platforms. A protocol of systematic review and meta-analysis of COVID-19 vaccine clinical trial studies.. [DOI: 10.1101/2022.05.18.22275247] [Reference Citation Analysis]
|
| 11 |
Machado BAS, Hodel KVS, Fonseca LMDS, Pires VC, Mascarenhas LAB, da Silva Andrade LPC, Moret MA, Badaró R. The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines. Vaccines 2022;10:591. [DOI: 10.3390/vaccines10040591] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 12 |
Unlu U, Celtek NY, Erdogdu Ceylan E, Demir O. COVID-19 Pandemic and Vaccination from The Perspective of University Students: Knowledge, Attitudes and Practices. Euras J Fam Med 2022;11:75-86. [DOI: 10.33880/ejfm.2022110110] [Reference Citation Analysis]
|
| 13 |
Chen J, Yunnan Center for Disease Control and Prevention, Kunming City, Yunnan Province, China, Qiu Y, Shi Y, Wu W, Zheng E, Xu L, Jia M. Uncovering the Impact of Control Strategies on the Transmission Pattern of SARS-CoV-2 — Ruili City, Yunnan Province, China, February–March 2022. China CDC Weekly 2022;4:1032-1038. [DOI: 10.46234/ccdcw2022.208] [Reference Citation Analysis]
|
